Beta cell function during rapamycin monotherapy in long-term type 1 diabetes

被引:0
作者
L. Piemonti
P. Maffi
L. Monti
V. Lampasona
G. Perseghin
P. Magistretti
A. Secchi
E. Bonifacio
机构
[1] Diabetes Research Institute (HSR-DRI),Cardiodiabetes and Core Lab, Division of Metabolic and Cardiovascular Sciences
[2] San Raffaele Scientific Institute,Unit of Genomics for the Diagnosis of Human Pathologies, Center for Genomics, Bioinformatics and Biostatistics
[3] San Raffaele Scientific Institute,Unit of Obesity and Metabolic Related Diseases, Division of Metabolic and Cardiovascular Sciences
[4] San Raffaele Scientific Institute,Department of Sport, Nutrition and Health Sciences
[5] San Raffaele Scientific Institute,Unit of Clinical Transplant, Division of Immunology, Transplantation and Infectious Diseases
[6] Università degli Studi di Milano,Center for Regenerative Therapies Dresden
[7] Università Vita-Salute San Raffaele,undefined
[8] Dresden University of Technology,undefined
来源
Diabetologia | 2011年 / 54卷
关键词
C-peptide; Humans; Long-term type 1 diabetes; Rapamycin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:433 / 439
页数:6
相关论文
共 101 条
[1]  
Liu EH(2009)Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft Diabetologia 52 1369-1380
[2]  
Digon BJ(2009)Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes Diabetes Care 32 2251-2257
[3]  
Hirshberg B(2003)Beta-cell regeneration in a patient with type 1 diabetes mellitus who was receiving immunosuppressive therapy Ann Intern Med 139 W81-172
[4]  
Rother KI(1978)Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement Diabetologia 15 169-147
[5]  
Spain LM(1983)Prevalence of residual B cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes Diabetologia 24 141-523
[6]  
Wesley RA(1998)Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial Ann Intern Med 128 517-264
[7]  
Kuroda A(1978)Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes Diabetes 27 262-836
[8]  
Yamasaki Y(2003)Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial Diab Care 26 832-274
[9]  
Imagawa A(1986)The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom Diabetologia 29 267-261
[10]  
Eff C(1978)Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus Diabetes 27 251-700